China
Nick Redfearn, head of enforcement at Rouse and a classic car enthusiast, explains the sudden viral appearance of classic car restomod parts from China and the impact of IP in this new trade
Tingxi Huo joins our ‘Five minutes with’ series to discuss boosting the value of clients’ IP and the importance of reflection
The firm, which has also hired a senior trademark leader to lead operations in the region, believes greater China to be one of the most important IP jurisdictions
In the final part of a series on challenging patent invalidation decisions in China, lawyers at Spruson & Ferguson and Marshall Gerstein share how courts adjudicate appeals
Sponsored
Sponsored
-
Sponsored by Wanhuida Intellectual PropertyPaul Ranjard, Huang Hui, and Zhu Zhigang of Wanhuida Intellectual Property explain the proposed amendments to China’s Trademark Law, their ramifications, and the persisting issue surrounding the ‘right to use’ -
Sponsored by Wanhuida Intellectual PropertyXiaoping Wu and Jicheng Yang of Wanhuida Intellectual Property analyse an invalidation decision that addresses how dosage and administration features affect the inventiveness assessment of pharmaceutical use claims in China
-
Sponsored by CCPIT Patent and Trademark Law OfficeThe revised Patent Examination Guidelines foster innovation by redefining plant varieties, says Juhua Luo of CCPIT Patent and Trademark Law Office
-
Sponsored by CCPIT Patent and Trademark Law OfficeNew CNIPA examination practices on non-use cancellation raise evidentiary requirements for petitioners. Ling Zhao of CCPIT Patent and Trademark Law Office highlights the implications for registrants and enforcement strategies in China
-
Sponsored by Wanhuida Intellectual PropertyYue Guan of Wanhuida Intellectual Property explains how the CNIPA’s rulings on mirogabalin besylate tablets highlight the importance of formulation patent drafting and claim amendments in China’s drug patent landscape
-
Sponsored by CCPIT Patent and Trademark Law OfficeHongxia Wu of CCPIT Patent and Trademark Law Office outlines the potential impact of the 2025 amendments on overseas companies operating in the country
